Stoke Therapeutics, Inc. (STOK)
34.29
-0.08
(-0.23%)
USD |
NASDAQ |
Feb 20, 16:00
34.28
-0.01
(-0.03%)
After-Hours: 20:00
Stoke Therapeutics Profit Margin (Quarterly) : -360.7% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | -2.24% |
| Insmed, Inc. | -124.5% |
| Pfizer Inc. | -9.34% |
| Mirum Pharmaceuticals, Inc. | 2.18% |
| Moderna, Inc. | -121.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.95% |
| Return on Assets | 11.82% |
| Return on Invested Capital | 13.73% |
| Gross Profit Margin (Quarterly) | 90.70% |
| Operating Margin (Quarterly) | -405.3% |
| Return on Net Operating Assets | 197.6% |